Integrin Cytoplasmic Tail Interactions

Por Morse, Elizabeth M., Brahme, Nina N., Calderwood, David A.
Publicado em 2014

Signaling, Regulation, and Specificity of the Type II p21-activated Kinases

Por Ha, Byung Hak, Morse, Elizabeth M., Turk, Benjamin E., Boggon, Titus J.
Publicado no J Biol Chem (2015)

PAK6 targets to cell–cell adhesions through its N-terminus in a Cdc42-dependent manner to drive epithelial colony escape

Por Morse, Elizabeth M., Sun, Xiaowen, Olberding, Jordan R., Ha, Byung Hak, Boggon, Titus J., Calderwood, David A.
Publicado no J Cell Sci (2016)

Substance abuse treatment in human immunodeficiency virus: The role of patient–provider discussions

Por Korthuis, Philip Todd, Josephs, Joshua S., Fleishman, John A., Hellinger, James, Himelhoch, Seth, Chander, Geetanjali, Morse, Elizabeth B., Gebo, Kelly A.
Publicado em 2008

TRB3 is stimulated in diabetic kidneys, regulated by the ER stress marker CHOP, and is a suppressor of podocyte MCP-1

Por Morse, Elizabeth, Schroth, Jana, You, Young-Hyun, Pizzo, Donald P., Okada, Shinichi, RamachandraRao, Satish, Vallon, Volker, Sharma, Kumar, Cunard, Robyn
Publicado em 2010

Zasp regulates integrin activation

Por Bouaouina, Mohamed, Jani, Klodiana, Long, Jenny Y., Czerniecki, Stefan, Morse, Elizabeth M., Ellis, Stephanie J., Tanentzapf, Guy, Schöck, Frieder, Calderwood, David A.
Publicado em 2012

Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity

Por Lundström, Wangko, Highfill, Steven, Walsh, Scott T. R., Beq, Stephanie, Morse, Elizabeth, Kockum, Ingrid, Alfredsson, Lars, Olsson, Tomas, Hillert, Jan, Mackall, Crystal L.
Publicado em 2013

Substrate and Inhibitor Specificity of the Type II p21-Activated Kinase, PAK6

Por Gao, Jia, Ha, Byung Hak, Lou, Hua Jane, Morse, Elizabeth M., Zhang, Rong, Calderwood, David A., Turk, Benjamin E., Boggon, Titus J.
Publicado em 2013

A Novel HDAC Inhibitor with a Hydroxy-Pyrimidine Scaffold

Por Kemp, Melissa M., Wang, Qiu, Fuller, Jason H., West, Nathan, Martinez, Nicole M., Morse, Elizabeth M., Weïwer, Michel, Schreiber, Stuart L., Bradner, James E., Koehler, Angela N.
Publicado em 2011

Defining the role of syndecan-4 in mechanotransduction using surface-modification approaches

Por Bellin, Robert M., Kubicek, James D., Frigault, Matthew J., Kamien, Andrew J., Steward, Robert L., Barnes, Hillary M., DiGiacomo, Michael B., Duncan, Luke J., Edgerly, Christina K., Morse, Elizabeth M., Park, Chan Young, Fredberg, Jeffrey J., Cheng, Chao-Min, LeDuc, Philip R.
Publicado em 2009

Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease

Por Bradner, James E., Mak, Raymond, Tanguturi, Shyam K., Mazitschek, Ralph, Haggarty, Stephen J., Ross, Kenneth, Chang, Cindy Y., Bosco, Jocelyn, West, Nathan, Morse, Elizabeth, Lin, Katherine, Shen, John Paul, Kwiatkowski, Nicholas P., Gheldof, Nele, Dekker, Job, DeAngelo, Daniel J., Carr, Steven A., Schreiber, Stuart L., Golub, Todd R., Ebert, Benjamin L.
Publicado em 2010

Selective inhibition of BET bromodomains

Por Filippakopoulos, Panagis, Qi, Jun, Picaud, Sarah, Shen, Yao, Smith, William B., Fedorov, Oleg, Morse, Elizabeth M., Keates, Tracey, Hickman, Tyler T., Felletar, Ildiko, Philpott, Martin, Munro, Shonagh, McKeown, Michael R., Wang, Yuchuan, Christie, Amanda L., West, Nathan, Cameron, Michael J., Schwartz, Brian, Heightman, Tom D., La Thangue, Nicholas, French, Christopher A., Wiest, Olaf, Kung, Andrew L., Knapp, Stefan, Bradner, James E.
Publicado em 2010